Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Daniel Lewis, Orange Capital Go Activist On PHH Corporation

PHH Corporation (NYSE:PHH) recently became an addition to the equity portfolio of Orange Capital, an activist hedge fund managed by Daniel Lewis. In a 13D filing with the Securities and Exchange Commission, Orange Capital disclosed the acquisition of almost 2.9 million shares, with the stake’s value amounting to $64.4 million, at the current price of PHH Corporation’s stock. In addition, Orange Capital said that it considers PHH an “attractive investment opportunity” and expressed some ideas that might help the company to bring more returns for shareholders.

PHH Corporation

“We believe there are both immediate and near-term options available to management that would improve shareholder returns while preserving, and in most cases enhancing, the Company’s credit profile. Specifically, we have four recommendations for management and the Board of Directors:

1)Create a captive finance vehicle which would own a significant stake in the Company’s newly originated and existing excess MSRs<

2)Hire a financial advisor to pursue a tax-efficient sale or IPO of Fleet Management

3)Immediately commence a share repurchase program or tender offer for $150 million of the Company’s common stock

4)After resolving outstanding repurchase obligations and securing new financing for newly originated MSRs, offer to exchange the 6% convertible notes due 2017 for a combination of cash and common stock

With these steps, we believe PHH’s share price would likely increase by over 67%,” Orange Capital said in a letter addressed to Glen A. Messina, President and Chief Executive Officer of PHH Corporation.

In addition to Orange Capital, which through the acquisition currently owns 5.0% of PHH Corporation, we should mention some other hedge funds that held shares of the company in the latest round of 13F filings. These hedge funds are: Senator Investment Group, managed by Doug Silverman and Alexander Klabin, Matt Sirovich and Jeremy Mindich’s Scopia Capital, and Israel Englander’s Millennium Management among others.

Recommended Reading:

Is Leap Wireless a Good Investment?

What Jim Chanos Thinks About China, Apple Inc. (AAPL) & Where He’s Looking Next

Mario Gabelli On Tesla Motors Inc (TSLA) & Elon Musk

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!